We explain to Dr. Benjamin (corresponding author) about why low-dose computed tomography reduce lung cancer mortality without significantly reducing all-cause mortality. We also conduct an up-to-date meta-analysis to evaluate low-dose computed tomography clinical effectiveness compared with usual care of lung cancer screening.
Mendeley helps you to discover research relevant for your work.
CITATION STYLE
Huang, K. L., Wang, S. Y., Lu, W. C., Chang, Y. H., Su, J., & Lu, Y. T. (2020). Author response to “lack of benefit from low dose computed tomography in screening for lung cancer.” BMC Pulmonary Medicine, 20(1). https://doi.org/10.1186/s12890-020-01247-y